First biosimilar marketing initiatives by MCOs in U.S. 2015
This survey depicts the initiatives managed care organizations (MCOs) are planning to undertake when the first biosimilar is marketed in the United States, as of 2015. The survey shows that 93 percent of MCOs plan to undergo a review by the pharmacy and therapeutics committee.